Molecular and phylogenetic analysis of the haemagglutinin gene of pandemic influenza H1N1 2009 viruses associated with severe and fatal infections

Virus Research

Volumn 151, Issue 2, 2010, Pages 192-199

  Melidou, Angeliki ^a   Gioula, Georgia ^a   Exindari, Maria ^a   Chatzidimitriou, Dimitris ^a   Diza, Eudoxia ^a   Malisiovas, Nikolaos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Fatal; Greece; Haemagglutinin; Influenza A(H1N1); Pandemic; Phylogenetic; Severe

Indexed keywords

HEMAGGLUTININ 1; INFLUENZA VIRUS HEMAGGLUTININ; UNCLASSIFIED DRUG; H1N1 VIRUS HEMAGGLUTININ; VIRULENCE FACTOR; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GREECE; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS STRAIN; AMINO ACID SUBSTITUTION; CLUSTER ANALYSIS; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETICS; INFLUENZA; ISOLATION AND PURIFICATION; MIDDLE AGED; MISSENSE MUTATION; MOLECULAR GENETICS; PATHOGENICITY; PATHOLOGY; SEQUENCE HOMOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; CLUSTER ANALYSIS; FEMALE; GREECE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; POLYMORPHISM, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SEVERITY OF ILLNESS INDEX; VIRULENCE FACTORS; YOUNG ADULT;

INFLUENZA A VIRUS;

EID: 77954218539     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.05.005     Document Type: Article

References (29)

1. Arora D.J., N'Diaye M., Dea S. Genomic study of hemagglutinins of swine influenza (H1N1) viruses associated with acute and chronic respiratory diseases in pigs. Arch. Virol. 1997, 142(2):401-412.
2. Brown I.H., Ludwig S., Olsen C.W., Hannoun C., Scholtissek C., Hinshaw V.S., Harris P.A., McCauley J.W., Strong I., Alexander D.J. Antigenic and genetic analyses of H1N1 influenza A viruses from European pigs. J. Gen. Virol. 1997, 78(3):553-562.
3. Centre of Disease Control CDC Realtime RTPCR Protocol for Detection and Characterization of Swine Influenza (Version 2009) 2009, CDC ref: #I-007-05.
4. Centers for Disease Control and Prevention (CDC) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 2009, 58(19):521-524.
5. Chen, et al. Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong. China J. Infect. Dis. 2010, 201(May (10)):1517-1521.
6. European Centre for Disease Control Pandemic Influenza A(H1N1) Virus Mutations Reported to be Associated with Severe Disease 2009, 23 December 2009.
7. Garten R.J., Davis C.T., Russel C.S., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
8. Glinsky G.V. Genomic analysis of pandemic (H1N1) 2009 reveals association of increasing disease severity with emergence of novel hemagglutinin mutations. Cell Cycle 2010, 9(5):958-970. PMID: 20160492.
9. Igarashi M., Ito K., Kida H., Takada A. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin. Virology 2008, 376(2):323-329.
10. Kilander A., Rykkvin R., Dudman S.G., Hungnes O. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 2010, 15(9). pii=19498.
11. Knipe D.M., Howley P.M. Fields Virology 2001, vol. 1:220-226. Lappincott Williams & Wilkins, Philadelphia. 4th ed.
12. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and clustal X version 2. Bioinformatics 2007, 23(21):2947-2948.
13. Luoh S.M., McGregor M.W., Hinshaw V.S. Hemagglutinin mutations related to antigenic variation in H1 swine influenza viruses. J. Virol. 1992, 66(2):1066-1073.
14. Mak G.C., Au K.W., Tai L.S., Chuang K.C., Cheng K.C., Shiu T.C., Lim W. Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill. 2010, 15(14). pii=19534.
15. Melidou A., Exindari M., Gioula G., Chatzidimitriou D., Pierroutsakos Y., Diza E. Human Influenza A(H3N2) viruses isolated in northern Greece since 2004: molecular and phylogenetic analysis and vaccine strain match. Virus Res. 2009, 145(2):220-226.
16. Peiris J.S.M., Poon L.L.M., Guan Y. Emergence of a novel swine origin influenza A virus (S-OIV) H1N1 virus in humans. J. Clin. Virol. 2009, 45:169-173.
17. Qi L., Kash J.C., Dugan V.G., Wang R., Jin G., Cunningham R.E., Taubenberger J.K. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J. Virol. 2009, 83(8):3754-3761.
18. Reid A.H., Janczewski T.A., Lourens R.M., Elliot A.J., Daniels R.S., et al. 1918 influenza pandemic caused by highly conserved viruses with two receptor binding variants. Emerg. Infect. Dis. 2003, 9:1249-1253.
19. Rott R. The pathogenic determinant of influenza virus. Vet. Microbiol. 1992, 33:303-310.
20. Shih A.C., Hsiao T.C., Shang H., Hsiung L.W. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. PNAS 2007, 104(15):6283-6288.
21. Shinya K., Ebina M., Yamada S., Ono M., Kasai N., Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006, 440:435-436.
22. Stevens J., Blixt O., Glaser L., Taubenberger J.K., Palese P., Paulson J.C., Wilson I.A. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 2006, 3355(5):1143-1155.
23. Sweet C., Smith M. Pathogenicity of influenza virus. Microbiol. Rev. 1980, 44:303-330.
24. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software version 4.0. Molecular Biology and Evolution 2007 2007, 10.1093/molbev/msm092.
25. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol. Rev. 1992, 56:152-179.
26. World Health and Organization Preliminary Review of D222G Amino Acid Substitution in the Haemagglutinin of Pandemic Influenza A (H1N1) 2009 Viruses 2009, 28 December 2009.
27. World Health Organization Outbreak news-swine influenza. WER 2009, 84(18):149-160.
28. Wilson I.A., Skehel J.J., Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981, 289:366-373.
29. Wilson J.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 1990, 8:737-771.